3- (2- (4- bromophenyl)- 1- methyl- 2- oxoethyl)- 4,5,6,7- tetrahydrobenzothiazol- 3- ium
an advanced glycation end products breaker; structure in first source
Also Known As:
3-(2-(4-bromophenyl)-1-methyl-2-oxoethyl)-4,5,6,7-tetrahydrobenzothiazol-3-ium bromide; BrPhMOE-TBI
Networked: 0
relevant articles (0 outcomes,
0 trials/studies)
Bio-Agent Context: Research Results